A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/513 (2006.01) A61K 9/127 (2006.01) A61K 31/282 (2006.01) A61K 31/4412 (2006.01) A61K 31/53 (2006.01) A61K 47/24 (2006.01) A61K 47/34 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2713673
An object of the present invention is to further enhance the antitumor effect when oxaliplatin is administered in combination with a combination drug containing tegafur, gimeracil and oteracil potassium. According to the present invention, by using oxaliplatin encapsulated in a liposome preparation, combination therapy of oxaliplatin plus a combination drug containing tegafur, gimeracil and oteracil potassium, is revealed to show remarkably enhanced antitumor effect without increasing side effects.
L'objet de l'invention est d'améliorer davantage l'effet antitumoral lorsque de l'oxaliplatine est utilisée en association avec une préparation mixte qui contient du tégafur, du gimeracil et de l'oteracil potassium. En utilisant de l'oxaliplatine sous la forme d'une préparation de liposome, lorsque la préparation de liposome est utilisée en association avec une préparation mixte contenant du tégafur, du gimeracil et de l'oteracil potassium, l'effet antitumoral peut être amélioré de façon importante sans accroître les effets secondaires indésirables.
Ishida Tatsuhiro
Kiwada Hiroshi
Marks & Clerk
Taiho Pharmaceutical Co. Ltd.
The University Of Tokushima
LandOfFree
Agent for enhancing anti-tumor effect comprising oxaliplatin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for enhancing anti-tumor effect comprising oxaliplatin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for enhancing anti-tumor effect comprising oxaliplatin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1714216